Amarantus BioScience
(OTC) AMBS
Amarantus BioScience Financials at a Glance
Market Cap
$600
Revenue (TTM)
$96.61K
Net Income (TTM)
$1.75M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
42.83 (High)
Dividend
$0.00
Beta (Volatility)
42.83 (High)
Price
$0.00
Volume
2,057,350
Open
$0.00
Price
$0.00
Volume
2,057,350
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
42.83 (High)
Price
$0.00
Volume
2,057,350
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
AMBS News
AMBS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amarantus BioScience
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Gerald E. Commissiong
Website
www.amarantus.comHeadquarters
New York City, NY 10005, US
AMBS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-3%
Net Income Margin
-50%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-47%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$600.00
Shares Outstanding
630.41M
Volume
2.06M
Short Interest
0.00%
Avg. Volume
36.09K
Financials (TTM)
Gross Profit
$95.33K
Operating Income
$268.00K
EBITDA
$4.53M
Operating Cash Flow
$4.50M
Capital Expenditure
$0.00
Free Cash Flow
$4.50M
Cash & ST Invst.
$0.00
Total Debt
$19.14M
Amarantus BioScience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.27K
N/A
Gross Profit
$1.27K
N/A
Gross Margin
100.00%
N/A
Market Cap
$600.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$52.03K
+98.3%
EBITDA
$60.00K
+98.0%
Quarterly Fundamentals
Net Cash
$19.12M
+0.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$19.12M
-0.4%
Return on Assets
-46.65%
N/A
Return on Invested Capital
1.09%
N/A
Free Cash Flow
$7.97K
+100.3%
Operating Cash Flow
$7.97K
+100.3%